期刊文献+
共找到20篇文章
< 1 >
每页显示 20 50 100
Increased Midkine and Estrogen Receptor-β Expression in Human Non-Small Cell Lung Cancer 被引量:1
1
作者 Shi-hua Zhang Guang-feng Zhao +2 位作者 Ya-hong Huang Kai-hua Lu Ya-yi HOU 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2009年第4期255-264,共10页
Objective: Midkine (MK), a new member of the heparin-binding growth factor family, has been found recently to have a high expression level in many tumor specimens including lung carcinoma. Estrogens may be involved... Objective: Midkine (MK), a new member of the heparin-binding growth factor family, has been found recently to have a high expression level in many tumor specimens including lung carcinoma. Estrogens may be involved in lung carcinogenesis, and estrogen receptors, mainly estrogen receptor-β (ER-β), are present and functional in normal lung and tumor cell lines and tissues. In addition, estrogens and growth factors may promote the progression of human non-small cell lung cancer (NSCLC). Previously, we have immunohistochemically demonstrated that MK and ER-β proteins were overexpressed in NSCLC and their expression levels were both significantly negatively correlated with the pathological classification. The purpose of this study was to further verify their expression and its correlation with NSCLC. Methods: Taking NSCLC tissues and their corresponding paraneoplastic and normal lung as research objects, we further examined the expression of MK and ER-β by meas of RT-PCR, in situ hybridization and Western blot analyses at the levels of messenger RNA (mRNA) and protein, respectively. Results: The increased MK and ER-β mRNA expression was found in NSCLC by RT-PCR and in situ hybridization analyses. Furthermore, Western blot analysis also displayed increased expression of MK and ER-β proteins in NSCLC. Finally, their correlation analysis at the levels of mRNA and protein expression in NSCLC demonstrated that MK protein level was significantly correlated to estrogen receptor-β (P〈0.01, rs=0.535); in spite of their correlation at the mRNA level, there was no remarkable difference between MK and ER-β (P〉0.05, rs=0.178). Conclusion: All these results in the present study confirmed that MK and ER-β were overexpressed in human NSCLC. 展开更多
关键词 Midkine (MK) estrogen receptor-β er-β) Non-small cell lung cancer (NSCLC)
下载PDF
SAH抑制内皮细胞增殖和ER-α表达作用 被引量:2
2
作者 余小平 刘驰 +3 位作者 夏敏 王庆 迟东升 凌文华 《中国公共卫生》 CAS CSCD 北大核心 2008年第1期119-121,共3页
目的探讨胞内S-腺苷同型半胱氨酸(SAH)升高抑制血管内皮细胞增殖和雌激素受体-α(ER-α)表达变化的关系。方法以永生化的人脐静脉内皮细胞(HUVEC)为研究对象,经不同浓度的S-腺苷同型半胱氨酸水解酶(SAHH)强效抑制剂3-deazaadenosine(DZA... 目的探讨胞内S-腺苷同型半胱氨酸(SAH)升高抑制血管内皮细胞增殖和雌激素受体-α(ER-α)表达变化的关系。方法以永生化的人脐静脉内皮细胞(HUVEC)为研究对象,经不同浓度的S-腺苷同型半胱氨酸水解酶(SAHH)强效抑制剂3-deazaadenosine(DZA)处理24,48,72 h。利用细胞计数法、流式细胞仪和脱氧核糖核酸转移酶缺口末端标记法(TUNEL)检测细胞的增殖凋亡能力,蛋白印迹法检测ER-α蛋白的表达,荧光定量-PCR(qRT-PCR)检测其mRNA表达,甲基化特异PCR法(MSP)检测ER-α基因启动子甲基化状态。结果经DZA处理后,HU-VEC增殖能力降低(主要受阻于G1/G0期),细胞凋亡率增加(P<0.05),ER-αmRNA和蛋白的相对表达量降低(P<0.05),但其启动子甲基化不发生改变。结论胞内SAH升高抑制HUVEC的增殖能力与ER-α的表达变化有关,但这种作用不是通过改变ER-α基因启动子的甲基化而实现。 展开更多
关键词 S-腺苷同型半胱氨酸 雌激素受体-Α 人脐静脉内皮细胞 甲基化
下载PDF
子宫内膜异位症伴不孕患者ER-α基因多态性与GnRH-a治疗效果的关系 被引量:3
3
作者 李江鹏 王建锋 +2 位作者 杨晶洁 马文娟 王恒 《中国性科学》 2020年第5期88-91,共4页
目的探讨雌激素受体-α(ER-α)基因多态性与子宫内膜异位症合并不孕患者行促性腺激素释放激素激动剂(GnRH-a)治疗效果的关系,明确是否存在与疗效有关的基因型。方法选取2016年3月至2018年3月西安市第四医院妇产科诊治并手术的93例子宫... 目的探讨雌激素受体-α(ER-α)基因多态性与子宫内膜异位症合并不孕患者行促性腺激素释放激素激动剂(GnRH-a)治疗效果的关系,明确是否存在与疗效有关的基因型。方法选取2016年3月至2018年3月西安市第四医院妇产科诊治并手术的93例子宫内膜异位症伴不孕患者作为研究对象。进行ER-α基因多态性检测及基因分型,给予患者3个周期GnRH-a治疗,随访12个月比较不同ER-α基因型患者经GnRH-a治疗后妊娠成功率、复发率以及术后痛经评分差异。结果93例患者PvuⅡ-397 T>C多态位点3种基因型分别为:TT型27例(29.0%),TC型29例(31.2%),CC型37例(39.8%);XbaⅠ-351 A>G多态位点基因型分别为AA型18例(19.4%),AG型37例(39.8%),GG型38例(40.8%);PvuⅡ-397 T>C位点TT、TC、CC基因型患者妊娠成功、复发率、术后痛经评分比较,差异均无统计学意义(P>0.05);XbaⅠ-351 A>G位点AA、AG、GG基因型妊娠成功率、复发率、术后痛经评分比较,差异具有统计学意义(P<0.05)。结论ER-α基因XbaⅠ-351 A>G位点基因多态性与术后GnRH-a治疗子宫内膜异位症合并不孕患者疗效有关。 展开更多
关键词 子宫内膜异位症伴不孕 雌激素受体-Α 基因多态性 促性腺激素释放激素激动剂
下载PDF
Expression of voltage.gated sodium channel Nav1.5 in non.metastatic colon cancer and its associations with estrogen receptor(ER)-βexpression and clinical outcomes 被引量:7
4
作者 Jianhong Peng Qingjian Ou +7 位作者 Xiaojun Wu Rongxin Zhang Qian Zhao Wu Jiang Zhenhai Lu Desen Wan Zhizhong Pan Yujing Fang 《Chinese Journal of Cancer》 SCIE CAS CSCD 2017年第12期694-703,共10页
Background: Voltage-gated sodium channel 1.5(Nav1.5) potentially promotes the migratory and invasive behaviors of colon cancer cells. Hitherto, the prognostic significance of Nav1.5 expression remains undetermined. Th... Background: Voltage-gated sodium channel 1.5(Nav1.5) potentially promotes the migratory and invasive behaviors of colon cancer cells. Hitherto, the prognostic significance of Nav1.5 expression remains undetermined. The present study aimed to explore the associations of Nav1.5 expression with clinical outcomes and estrogen receptor-β(ER-β)expression in non-metastatic colon cancer patients receiving radical resection.Methods: A total of 269 consecutive patients with pathologically confirmed stages Ⅰ-Ⅲ colon cancer who underwent radical resection were selected. Nav1.5 and ER-β expression was detected by using immunohistochemistry(IHC)on tissue microarray constructed from paraffin-embedded specimens. IHC score was determined according to the percentage and intensity of positively stained cells. Statistical analysis was performed with the X-tile method, k coefficient, Chi square test or Fisher's exact test, logistic regression, log-rank test, and Cox proportional hazards models.Results: We found that Nav1.5 was commonly expressed in tumor tissues with higher mean IHC score as compared with matched tumor-adjacent normal tissues(5.1 ± 3.5 vs. 3.5 ± 2.7, P < 0.001).The high expression of Nav1.5 in colon cancer tissues was associated with high preoperative carcinoembryonic antigen level [odds ratio(OR) = 2.980;95% confidential interval(CI)1.163-7.632; P = 0.023] and high ER-β expression(OR = 2.808; 95% CI 1.243-6.343;p = 0.00 3). Log-rank test results showed that high Nav1.5 expression contributed to a low 5-year disease-free survival(DFS) rate in colon cancer patients(77.2% vs. 92.1%, P = 0.048), especially in patients with high ER-β expression tumor(76.2% vs. 91.3%, P = 0.032). Analysis with Cox proportional hazards model demonstrated that high Nav1.5 expression[hazard ratio(HR) = 2.738; 95% CI 1.100-6.819;P = 0.030] and lymph node metastasis(HR = 2.633; 95% CI 1.632-4.248; P < 0.001) were prognostic factors for unfavorable DFS in colon cancer patients.Conclusions: High expression of Nav1.5 was associated with high expression of ER-β and indicated unfavorable oncologic prognosis in patients with non-metastatic colon cancer. 展开更多
关键词 NAV1.5 estrogen receptor-β COLON cancer Clinical OUTCOME
下载PDF
phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study 被引量:3
5
作者 Mariabeatrice Principi Alfredo Di Leo +8 位作者 Maria Pricci Maria Principia Scavo Raffaella Guido Sabina Tanzi Domenico Piscitelli Antonio Pisani Enzo Ierardi Maria Cristina Comelli Michele Barone 《World Journal of Gastroenterology》 SCIE CAS 2013年第27期4325-4333,共9页
AIM:To assess the safety and effect of the supplementation of a patented blend of dietary phytoestrogens and insoluble fibers on estrogen receptor (ER)-β and biological parameters in sporadic colonic adenomas. METHOD... AIM:To assess the safety and effect of the supplementation of a patented blend of dietary phytoestrogens and insoluble fibers on estrogen receptor (ER)-β and biological parameters in sporadic colonic adenomas. METHODS:A randomized, double-blind placebo-controlled trial was performed. Patients scheduled to undergo surveillance colonoscopy for previous sporadic colonic adenomas were identified, and 60 eligible patients were randomized to placebo or active dietary intervention (ADI) twice a day, for 60 d before surveillance colonoscopy. ADI was a mixture of 175 mg milk thistle extract, 20 mg secoisolariciresinol and 750 mg oat fiber extract. ER-β and ER-α expression, apoptosis and proliferation (Ki-67 LI) were assessed in colon samples. RESULTS:No adverse event related to ADI was recorded. ADI administration showed a significant increases in ER-β protein (0.822 ± 0.08 vs 0.768 ± 0.10, P = 0.04) and a general trend to an increase in ER-β LI (39.222 ± 2.69vs 37.708 ± 5.31,P = 0.06), ER-β/ER-α LI ratio (6.564 ± 10.04 vs 2.437 ± 1.53, P = 0.06), terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (35.592 ± 14.97 vs 31.541 ± 11.54, P = 0.07) and Ki-67 (53.923 ± 20.91 vs 44.833 ± 10.38, P = 0.07) approximating statistical significance. A significant increase of ER-β protein (0.805 ± 0.13 vs 0.773 ± 0.13,P = 0.04), mRNA (2.278 ± 1.19vs 1.105 ± 1.07, P < 0.02) and LI (47.533 ± 15.47 vs 34.875 ± 16.67,P < 0.05) and a decrease of ER-α protein (0.423 ± 0.06vs 0.532 ± 0.11,P < 0.02) as well as a trend to increase of ER-β/ER-α protein in ADI vs placebo group were observed in patients without polyps (1.734 ± 0.20 vs 1.571 ± 0.42, P = 0.07). CONCLUSION:The role of ER-β on the control of apoptosis, and its amenability to dietary intervention, are supported in our study. 展开更多
关键词 estrogen receptor-β estrogen receptor-α Terminal deoxynucleotidyl transferase-mediated dUTP NICK end labeling Sporadic adenomatous POLYPOSIS PHYTOestrogenS Insoluble fibers
下载PDF
Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways 被引量:6
6
作者 Wenyan Tian Fei Teng +7 位作者 Jinping Gao Chao Gao Guoyan Liu Yanfang Zhang Shizhu Yu Wei Zhang Yingmei Wang Fengxia Xue 《Cancer Biology & Medicine》 SCIE CAS CSCD 2019年第1期55-65,共11页
Objective: Despite evidence that estrogens and insulin are involved in the development and progression of many cancers, their synergistic role in endometrial carcinoma(EC) has not been analyzed yet.Methods: Here, we i... Objective: Despite evidence that estrogens and insulin are involved in the development and progression of many cancers, their synergistic role in endometrial carcinoma(EC) has not been analyzed yet.Methods: Here, we investigated how estrogens act synergistically with insulin to promote EC progression. Cell growth in vitro and in vivo, effects of estradiol and insulin on apoptosis and cell cycle distribution, and expression and activation of estrogen receptor(ER), insulin receptor(InsR), and key proteins in the PI3K and MAPK pathways were examined after combined stimulation with estradiol and insulin.Results: Compared to EC cells treated with estradiol or insulin alone, those treated with both estradiol and insulin exhibited stronger stimulation. Estradiol significantly induced phosphorylation of InsR-β and IRS-1, whereas insulin significantly induced phosphorylation of ER-α. In addition, treatment with both insulin and estradiol together significantly increased the expression and phosphorylation of Akt, MAPK, and ERK. Notably, InsR-β inhibition had a limited effect on estradiol-dependent proliferation,cell cycle, and apoptosis, whereas ER-α inhibition had a limited insulin-dependent effect, in EC cell lines. Insulin and estradiol individually and synergistically promoted EC xenograft growth in mice.Conclusions: Estrogen and insulin play synergistic roles in EC carcinogenesis and progression by activating InsR-β and ER-α,promoting a crosstalk between them, and thereby resulting in the activation of downstream PI3K/Akt and MAPK/ERK signaling pathways. 展开更多
关键词 ENDOMETRIAL cancer(EC) estrogen INSULIN InsR-β er-α PI3K/Akt PATHWAY MAPK/ERK PATHWAY
下载PDF
Correlation and Significance of Midkine and Estrogen Receptor Beta Protein Expression in Non-Small Cell Lung Cancer 被引量:2
7
作者 Shihua Zhang Guangfeng Zhao +2 位作者 Qingling Wang Kaihua Lu Yayi Hou 《Chinese Journal of Clinical Oncology》 CSCD 2008年第6期418-423,共6页
OBJECTIVE Midkine (MK),a new member of the heparin-binding growth factor family,was found recently to have a highexpression level in many carcinoma specimens,including thoseof the esophagus,gall bladder,pancreas,color... OBJECTIVE Midkine (MK),a new member of the heparin-binding growth factor family,was found recently to have a highexpression level in many carcinoma specimens,including thoseof the esophagus,gall bladder,pancreas,colorectum,breast andlung.Estrogen receptor beta (ER-β),a recently cloned estrogenreceptor subtype,was also found to be highly expressed in lungtumor tissue,in contrast to a lower level of expression in normallung tissue.However,few relevant studies on these proteins havebeen published.The aims of our study were to investigate theexpression of midkine and ER-β proteins in non-small cell lungcancer (NSCLC) and to examine the relationship between theirexpression and the clinicopathologic data as well as to analyse thecorrelation of their expression in NSCLC.METHODS By immunohistochemistry,MK and ER-β were ex-amined in 24 surgically resected cases of NSCLC with their corre-sponding paraneoplastic and normal lung tissues.RESULTS MK and ER-β were overexpressed in NSCLC.Thelevels of MK and ER-β expression in NSCLC were found to be sig-nificantly negatively correlated with the pathological classification(P=0.042 and 0.021,respectively),and their expression decreasedwith a raise in the classification.Spearman's correlation analysisshowed that the correlation of their expression in NSCLC wasstrong (correlation coefficient[r_s]= 0.535,P=0.007<0.01).CONCLUSION The expression levels of MK and ER-β to someextent reflect the malignant degree of NSCLC,and their combineddetection may be of great value in early diagnosis,treatments ofpatients with NSCLC and can predict the prognoses. 展开更多
关键词 midkine (MK) estrogen receptor beta er-β) non-small cell lung cancer (NSCLC) immunohistochemistry.
下载PDF
Involvement of Estrogen Receptors in the Anxiolytic-Like Effect of Phytoestrogen Genistein in Rats with 12-Weeks Postovariectomy
8
作者 Juan Francisco Rodríguez-Landa Fabiola Hernández-López Margarita Saavedra 《Pharmacology & Pharmacy》 2012年第4期439-446,共8页
Phytoestrogens are natural compounds found in some vegetables, and they replicate many of the physiochemical and physiological properties of estrogens, including the regulation of mood. The phytoestrogen genistein exe... Phytoestrogens are natural compounds found in some vegetables, and they replicate many of the physiochemical and physiological properties of estrogens, including the regulation of mood. The phytoestrogen genistein exerts anxiolytic-like effects in rats with a chronic absence of ovarian hormones, but the mechanism involved in this effect remains to be explored. The present study explored the participation of estrogen receptor-β in the anxiolytic-like effect of genistein (1.0 mg/kg, i.p., for 4 days) in Wistar rats with 12-weeks postovariectomy, considered as experimental model of post-surgical menopause. In the light/dark test, a useful tool for anxiety study and for the screening of anxiolytic drugs, genistein reduced the latency to enter and increased the time spent in the light compartment and significantly increased the frequency and time spent exploring the light compartment compared with the control group, which is considered as an anxiolytic-like effect at experimental level. All behavioral effects produced by genistein in the light/dark test were blocked by previous tamoxifen administration (5.0 mg/kg, s.c., for 6 days), a non selective antagonist for estrogen receptor-β. The effects produced by genistein or tamoxifen in this test were not related to significant changes in general motor activity evaluated in the open field test. In conclusion, the specific contribution of present investigation was identify that estrogen receptor-β is involved in the anxiolytic-like effect produced by phytoestrogen genistein in rats with a long-term absence of ovarian hormones;supporting the hypothesis that estrogen receptor-β participates in the regulation of anxiety associated with low concentration of ovarian hormones and in the anxiolytic-like effects produced by natural estrogenic compounds such as phytoestrogens. 展开更多
关键词 ANXIETY GENISTEIN PHYTOestrogen estrogen receptor-β Light/Dark Test TAMOXIFEN
下载PDF
逆针灸对去卵巢大鼠子宫保护效应的观察 被引量:19
9
作者 李晓泓 郑玲 +7 位作者 翟景慧 解秸萍 张露芬 周军 周登芳 何玉伟 曲黎敏 田阳春 《针刺研究》 CAS CSCD 2008年第4期229-234,共6页
目的:探讨逆针灸"关元"穴对随后去卵巢更年期模型大鼠子宫保护效应的部分机制。方法:将3.5月龄SD雌性大鼠80只随机分为5组:正常组、假手术组、去卵模型组、逆针组和逆灸组,每组16只。逆针组、逆灸组于大鼠去卵巢之前分别针刺... 目的:探讨逆针灸"关元"穴对随后去卵巢更年期模型大鼠子宫保护效应的部分机制。方法:将3.5月龄SD雌性大鼠80只随机分为5组:正常组、假手术组、去卵模型组、逆针组和逆灸组,每组16只。逆针组、逆灸组于大鼠去卵巢之前分别针刺和艾灸"关元"穴,每周2次,共4周,其余3组与逆针、逆灸组同步以手抓放大鼠。至大鼠4.5月龄开始造模,去卵模型组、逆针组、逆灸组行卵巢切除术,假手术组仅切除卵巢周围少量脂肪,正常组不造模。大鼠于造模1个月后(即5.5月龄)取材,采用HE染色、免疫比浊、放射免疫、免疫组化、原位杂交等方法,观察逆针灸对随后去卵巢大鼠子宫组织形态、激素水平、雌激素受体与其基因表达及抗氧化相关指标的影响。结果:大鼠去卵巢后子宫组织形态有明显的衰退表现,子宫内雌二醇(E2)、孕酮(P)含量,雌激素受体(ER)-α及其基因表达,超氧化物歧化酶(SOD)、一氧化氮合酶(NOS)活性均明显降低,丙二醛(MDA)显著升高(均P<0.01)。与去卵模型组相比,逆灸、逆针组子宫结构的整体情况明显改善,且子宫内P含量、ER-α及基因表达明显升高,MDA显著下降(P<0.05,0.01);同时子宫E2含量,SOD、NOS活性亦有升高趋势,但无统计学意义(P>0.05)。结论:逆针灸"关元"穴对随后去卵巢更年期大鼠子宫退行性变有延缓作用,其保护效应可能与调节子宫局部E2、P含量,ER-α及其基因表达,提高机体抗氧化能力有关。 展开更多
关键词 逆针灸 去卵巢 子宫激素 雌激素受体-α及基因表达 抗氧化
下载PDF
壬基酚对雌鲫受体表达和雌二醇水平的影响 被引量:5
10
作者 刘青 魏华 +1 位作者 张高峰 吴楠 《水产学报》 CAS CSCD 北大核心 2007年第1期7-14,共8页
研究了环境激素壬基酚(4-NP)在雌鲫体内的对雌激素受体的表达和雌二醇水平的影响。雌鲫腹腔注射1、50、100 mg.kg-1的4-NP或1 mg.kg-1的E2,分别在24 h和48 h提取肝脏RNA用RT-PCR查看α型雌激素受体(ER-α)和CYP1A的表达情况和提取血清... 研究了环境激素壬基酚(4-NP)在雌鲫体内的对雌激素受体的表达和雌二醇水平的影响。雌鲫腹腔注射1、50、100 mg.kg-1的4-NP或1 mg.kg-1的E2,分别在24 h和48 h提取肝脏RNA用RT-PCR查看α型雌激素受体(ER-α)和CYP1A的表达情况和提取血清用荧光免疫法测定E2浓度。结果表明:1 mg.kg-1E2处理组的ER表达在24 h和48 h有显著性增加(P<0.01)。1 mg.kg-14-NP处理组在24 h ER表达与对照组比较有极显著性增加(P<0.01),在48 h有显著性增加(P<0.05),E2浓度在24 h与对照组比较有显著性下降(P<0.05),但在48 h后有所回升;CYP1A表达在处理后24 h有显著上调(P<0.05),在48 h后有极显著上调(P<0.01)。50 mg.kg-14-NP处理组在24 h ER表达与对照组比较有极显著性增加(P<0.01),在48 h有显著性增加(P<0.05),E2浓度在24 h和48 h与对照组比较有极显著性下降(P<0.01);CYP1A表达在处理后24 h有显著上调(P<0.05),在48 h后有极显著上调(P<0.01)。100 mg.kg-14-NP处理组ER表达在24 h和48 h与对照组比较有极显著性增加(P<0.01),E2浓度在24 h与对照组比较有显著性下降(P<0.05),在48 h有极显著性下降(P<0.01);CYP1A表达有极显著上调(P<0.01)。随着4-NP注射量的增加,ER表达也逐渐增加,而E2浓度逐渐减少。ER表达上调效应:E2>100 mg.kg-14-NP>50 mg.kg-14-NP>1 mg.kg-14-NP,100 mg.kg-1的4-NP对ER表达的上调效果接近于1 mg.kg-1E2的效果。E2下降效应:100 mg.kg-14-NP>50 mg.kg-14-NP>1 mg.kg-14-NP。NP对CYP1A表达有上调作用,并且表达随注射浓度上升而增强(具剂量-依赖效应)。以上结果表明,4-NP具有弱雌激素样效应,并且能抑制鲫鱼血清中E2的水平并使ER表达上调,为4-NP在鲫鱼体内通过ER途径实现内分泌扰乱效应的可能性提供了支持。 展开更多
关键词 壬基酚 α型雌激素受体 内分泌扰乱 雌激素样效应 内分泌干扰物
下载PDF
ERα和ERβ在非小细胞性肺癌组织中的表达及与其临床病理的相关性研究 被引量:3
11
作者 徐晓鸿 陈家斌 夏银稳 《实用癌症杂志》 2015年第8期1119-1122,共4页
目的探讨雌激素受体(ER)α和β在非小细胞性肺癌组织中的表达及与其临床病理的相关性。方法选取经组织病理学检查确诊的非小细胞肺癌220例患者作为研究对象。采用免疫组化方法检测ERα和ERβ表达水平。结果两种雌激素受体表达于细胞核内... 目的探讨雌激素受体(ER)α和β在非小细胞性肺癌组织中的表达及与其临床病理的相关性。方法选取经组织病理学检查确诊的非小细胞肺癌220例患者作为研究对象。采用免疫组化方法检测ERα和ERβ表达水平。结果两种雌激素受体表达于细胞核内,其中ERα阳性表达率为4.09%,ERβ阳性表达率为86.36%;ERα阳性表达与临床分期、病理分化程度有关:Ⅰ期患者ERα阳性表达率高于分期晚的患者(9.38%>0.00%,χ2=12.121,P<0.01);高分化患者ERα阳性表达率高于中低分化患者(14.29%>3.00%>0.00%,χ2=14.756,P<0.01)。ERβ阳性表达与患者临床分期、分化程度及病理类型有关:Ⅰ期患者ERα阳性表达率最低(78.12%,χ2=10.732,P=0.01),腺癌及高分化非小细胞性肺癌患者ERβ具有更高表达率(70.7%,χ2=7.749,P=0.02;83.3%,χ2=12.738,P<0.01)。结论 ERα和ERβ在非小细胞肺癌患者中表达情况与其临床病理特点具有相关性,提示雌激素受体表达可能在非小细胞肺癌的发生、发展中起重要作用。 展开更多
关键词 非小细胞肺癌 雌激素受体Β 雌激素受体Α
下载PDF
肝组织内性甾体激素受体与慢性乙型肝炎病毒复制及其抗原表达的相关性 被引量:1
12
作者 王荣芋 张小楠 +4 位作者 张占卿 陆伟 沈芳 冯艳玲 袁正宏 《肝脏》 2014年第10期741-751,共11页
目的探讨肝组织内雄激素受体(AR)和雌激素受体-α(ERα)含量对慢性乙型肝炎(CHB)患者血清HBV DNA载量、HBsAg水平和肝组织内HBsAg、HBcAg表达水平影响。方法 135例经肝活组织检查的CHB患者入选本研究,其中HBeAg阳性80例,HBeAg阴性55例... 目的探讨肝组织内雄激素受体(AR)和雌激素受体-α(ERα)含量对慢性乙型肝炎(CHB)患者血清HBV DNA载量、HBsAg水平和肝组织内HBsAg、HBcAg表达水平影响。方法 135例经肝活组织检查的CHB患者入选本研究,其中HBeAg阳性80例,HBeAg阴性55例。肝组织内AR mRNA和ERαmRNA采用反转录定量PCR检测。结果HBeAg阳性患者,血清HBV DNA载量与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(r=0.132,P=0.241和r=0.130,P=0.249),血清HBsAg水平与肝组织内AR mRNA和ERαmRNA含量均呈显著正相关(r=0.355,P=0.001和r=0.246,P=0.028);肝组织内HBcAg表达水平与肝组织内AR mRNA和ERαmRNA含量均呈显著正相关(rs=0.438,P=0.000和rs=0.352,P=0.002),肝组织内HBsAg表达水平与肝组织内AR mRNA和ERαmRNA含量无显著相关性(rs=0.112,P=0.333和rs=0.024,P=0.836)。HBeAg阴性患者,血清HBV DNA载量与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(r=-0.256,P=0.061和r=-0.121,P=0.385),血清HBsAg水平与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(r=0.130,P=0.348和r=0.165,P=0.234);肝组织内HBcAg表达水平与肝组织内AR mRNA和ERαmRNA含量均无显著相关性(rs=-0.053,P=0.701和rs=-0.203,P=0.137),肝组织内HBsAg表达水平与肝组织内AR mRNA和ERαmRNA含量无显著相关性(rs=0.159,P=0.247和rs=0.192,P=0.160)。多因素方差分析和有序Logistic回归分析的结果显示,肝组织内AR mRNA为影响HBeAg阳性患者血清HBsAg水平和肝组织内HBcAg表达水平的独立因素。结论肝组织内AR表达水平是影响CHB患者HBV抗原表达的一个独立因素。 展开更多
关键词 雄激素受体 雌激素受体-Α 慢性乙型肝炎 病毒复制 抗原表达 estrogen receptor-α
下载PDF
Cadmium-induced neurotoxicity: still much ado 被引量:12
13
作者 Jacopo Junio Valerio Branca Gabriele Morucci Alessandra Pacini 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第11期1879-1882,共4页
Cadmium(Cd) is a highly toxic heavy metal that accumulates in living system and as such is currently one of the most important occupational and environmental pollutants. Cd reaches into the environment by anthropoge... Cadmium(Cd) is a highly toxic heavy metal that accumulates in living system and as such is currently one of the most important occupational and environmental pollutants. Cd reaches into the environment by anthropogenic mobilization and it is absorbed from tobacco consumption or ingestion of contaminated substances. Its extremely long biological half-life(approximately 20-30 years in humans) and low rate of excretion from the body cause cadmium storage predominantly in soft tissues(primarily, liver and kidneys) with a diversity of toxic effects such as nephrotoxicity, hepatotoxicity, endocrine and reproductive toxicities. Moreover, a Cd-dependent neurotoxicity has been also related to neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, amyotrophic lateral sclerosis, and multiple sclerosis. At the cellular level, Cd affects cell proliferation, differentiation, apoptosis and other cellular activities. Among all these mechanisms, the Cd-dependent interference in DNA repair mechanisms as well as the generation of reactive oxygen species, seem to be the most important causes of its cellular toxicity. Nevertheless, there is still much to find out about its mechanisms of action and ways to reduce health risks. This article gives a brief review of the relevant mechanisms that it would be worth investigating in order to deep inside cadmium toxicity. 展开更多
关键词 CADMIUM toxicity neurodegenerative disorders oxidative stress reactive oxygen species blood-brain barrier permeability METALLOTHIONEIN 17Β-ESTRADIOL G-protein-coupled estrogen receptor-30
下载PDF
A Meta-Analysis of Lymphatic Vessel Invasion Correlated with Pathologic Factors in Invasive Breast Cancer 被引量:4
14
作者 Sandi Shen Shizhen Zhong +2 位作者 Hai Lu Wenhua Huang Gaofang Xiao 《Journal of Cancer Therapy》 2015年第4期315-321,共7页
Objectives: The invasive breast cancer is divided into four clinical subtypes: Luminal A-like, Luminal B-like, HER-2 positive, and triple-negative according to the expression status of estrogen receptor (ER), progeste... Objectives: The invasive breast cancer is divided into four clinical subtypes: Luminal A-like, Luminal B-like, HER-2 positive, and triple-negative according to the expression status of estrogen receptor (ER), progesterone receptor(PR), human epidermal growth factor receptor-2 (HER-2) and Ki-67. The prognosis and treatment strategy vary with subtypes. The current studies have reported the relation between lymphatic vessel invasion (LVI) and the expression status of ER, PR, HER-2, Ki-67 in invasive breast cancer, but the results were debatable. So the meta-analysis was conducted to confirm the relation between LVI and the four factors. Methods: Literature was searched by entering the terms: breast AND (neoplasm OR cancer OR carcinoma) AND (lymphovascular OR “lymph vessel” OR “lymphatic vessel” invasion OR carcinoma embolus) AND (ER OR estrogen receptor OR PR OR progesterone receptor OR HER-2 OR human epidermal growth factor receptor-2 OR Ki-67 OR clinicopathological) in Pubmed. The merged odds ratio (OR) and 95% confidence interval (CI) were estimated using fixed-effect model. Review Manager 5.2 was used to analysis the relation between LVI and the expression status of ER, PR, HER-2, Ki-67 in invasive breast cancer respectively. The fail-safe number was used to estimate publication bias. Results: The analysis included 5 studies, LVI positive rate was significant lower in ER positive, PR positive, HER-2 negative, low Ki-67 expression group statistically. The OR and 95% CI were 0.6(0.44 - 0.81), 0.64(0.43 - 0.95), 1.52(1.03 - 2.24), 5.29(1.53 - 18.35) respectively.Conclusions:?LVI was significantly correlated with the expression status of ER, PR, HER-2 and Ki-67 in invasive breast cancer. Furthermore, LVI was consistent with poor prognostic expression status of the four factors. 展开更多
关键词 LYMPHATIC Vessel Invasion estrogen RECEPTOR PROGESTERONE RECEPTOR Human EPIDERMAL Growth Factor receptor-2 Ki-67 Breast Cancer
下载PDF
TGF-β stimulation of EMT programs elicits non-genomic ER-α activity and anti-estrogen resistance in breast cancer cells 被引量:2
15
作者 Maozhen Tian William P.Schiemann 《Journal of Cancer Metastasis and Treatment》 CAS 2017年第1期150-160,共11页
Aim:Estrogen receptor-α(ER-α)activation drives the progression of luminal breast cancers.Signaling by transforming growth factor-β(TGF-β)typically opposes the actions of ER-α;it also induces epithelial-mesenchyma... Aim:Estrogen receptor-α(ER-α)activation drives the progression of luminal breast cancers.Signaling by transforming growth factor-β(TGF-β)typically opposes the actions of ER-α;it also induces epithelial-mesenchymal transition(EMT)programs that promote breast cancer dissemination,stemness and chemoresistance.The impact of EMT programs on nongenomic ER-αsignaling remains unknown and was studied herein.Methods:MCF-7 and BT474 cells were stimulated with TGF-βto induce EMT programs,at which point ER-αexpression,localization,and nongenomic interactions with receptor tyrosine kinases and MAP kinases(MAPKs)were determined.Cell sensitivity to anti-estrogens both before and after traversing the EMT program was also investigated.Results:TGF-β-stimulated MCF-7 and BT474 cells to acquire EMT phenotypes,which enhanced cytoplasmic accumulation of ER-αwithout altering its expression.Post-EMT cells exhibited:(1)elevated expression of EGFR and IGF1R,which together with Src formed cytoplasmic complexes with ER-α;(2)enhanced coupling of EGF,IGF-1 and estrogen to the activation of MAPKs;and(3)reduced sensitivity to tamoxifen,an event reversed by administration of small molecule inhibitors against the receptors for TGF-β,EGF,and IGF-1,as well as those against MAPKs.Conclusion:EMT stimulated by TGF-βpromotes anti-estrogen resistance by activating EGFR-,IGF1R-,and MAPK-dependent nongenomic ER-αsignaling. 展开更多
关键词 Breast cancer epithelial-mesenchymal transition estrogen receptor-α growth factor signal transduction tamoxifen resistance transforming growth factor-β
原文传递
Alteration of ERβ gene Rsal polymorphism may contribute to reduced fertilization rate and embryonic developmental competence
16
作者 Qiu-Fang Zhang Huai-Liang Feng +4 位作者 Lan Zhao Ping Liu Li Li Jie Yan Jie Qiao 《Asian Journal of Andrology》 SCIE CAS CSCD 2011年第2期317-321,共5页
This paper aims to determine the possible role of estrogen receptor-β (ERβ) gene Rsal polymorphism on sperm fertility and early embryonic development in humans. Three groups of Chinese men were recruited: in vitr... This paper aims to determine the possible role of estrogen receptor-β (ERβ) gene Rsal polymorphism on sperm fertility and early embryonic development in humans. Three groups of Chinese men were recruited: in vitro fertilization (IVF) group, including 374 couples who underwent conventional IVF; intracytoplasmic sperm injection (ICSI) group, including 294 couples who underwent an ICSI procedure using ejaculated sperm; and azoospermic group, consisting of 197 couples who underwent ICSI using either testis or epididymis sperm. Rsal polymorphism in the ERβ gene was detected by polymerase chain reaction (PCR)-restriction fragment length polymorphism technique; fertilization and high-quality embryo rates were evaluated for each group. In each group, no significant differences were found in the overall rates of fertilization and high-quality embryos among GG, AG and AA genotypes. However, the proportion of cycles possessing a satisfactory high-quality embryo rate with the AA genotype was significantly lower than that in the wild-type GG genotype from each group. These results demonstrated that sperm possessing the ERβ RsalA genotype may have reduced fertilization ability and decreased early embryonic developmental potential, which could directly or indirectly contribute to the low fertilization rate and early embryonic developmental arrest in some cases. 展开更多
关键词 embryo development estrogen receptor-β gene FERTILIZATION intracytoplasmic sperm injection in vitro fertilization poly-morphism
下载PDF
Correlation of expression of ER,PR and c-erbB-2 with ultrasonographic features in invasive ductal cancer of breast
17
作者 Qiao-Ling Zhao1,Fen Li2,Shao-Xue Duan1,Hui-Lian Hou3 1.Department of Ultrasound 2.Maternal and Child Healthcare Center 3.Department of Pathology,the First Affiliated Hospital,Medical School of Xi’an Jiaotong University,Xi’an 710061,China 《Journal of Pharmaceutical Analysis》 SCIE CAS 2010年第4期273-276,共4页
Objective To analyze the relationship of the expression level of estrogen receptor(ER),progesterone receptor(PR)and human epidermal growth factor receptor-2(HER-2,c-erbB-2)of breast invasive ductal carcinoma(IDC)with ... Objective To analyze the relationship of the expression level of estrogen receptor(ER),progesterone receptor(PR)and human epidermal growth factor receptor-2(HER-2,c-erbB-2)of breast invasive ductal carcinoma(IDC)with ultrasonographic characteristics.Methods Totally 104 patients with IDCs confirmed pathologically were involved in this study.ER,PR and c-erbB-2 expression in the IDC specimens was determined by immunohistochemical staining technique.The correlation between the ultrasonographic features and the positive expression of ER,PR or c-erbB-2 was analyzed.Results The positive expression rate of ER and PR in the group with tumor spiculation sign and posterior acoustic attenuation was higher than that in the group without.The positive expression rate of ER differed significantly(P<0.05)while that of PR did not(P>0.05).The over-expression rate of c-erbB-2 in the group of microcalcification,sufficient blood flow and axillary lymph node metastasis was higher than that in the group of non-microcalcification,deficient blood flow or without axillary lymph node metastasis(P<0.05).The expression of ER,PR and c-erbB-2 was not related to the size of tumor(P>0.05).Conclusion The expression of ER and c-erbB-2 is closely related to the ultrasonographic characteristics of IDC,which may,to some extent,reflect the expression level of ER and c-erbB-2. 展开更多
关键词 breast tumor ultrasound estrogen receptor(ER) progesterone receptor(PR) human epidermal growth factor receptor-2(Her-2 c-erbB-2)
下载PDF
Quantitative profiles of the mRNAs of ER-α and its novel variant ER-α36 in breast cancers and matched normal tissues 被引量:2
18
作者 Yi ZHENG Jing ZHANG +7 位作者 Zhen-zhen XU Jian-ming SHENG Xiao-chen ZHANG Hao-hao WANG Xiao-dong TENG Xiao-jiao LIU Jiang CAO Li-song TENG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2010年第2期144-150,共7页
Objective: The novel estrogen receptor-α (ER-α) variant ER-α36 is reported to be functional in the es-trogen signaling pathway and is related to tamoxifen resistance in breast cancer. However, ER-α36 tends to be a... Objective: The novel estrogen receptor-α (ER-α) variant ER-α36 is reported to be functional in the es-trogen signaling pathway and is related to tamoxifen resistance in breast cancer. However, ER-α36 tends to be a favorable factor for survival in patients without tamoxifen therapy. To investigate the mechanisms behind this paradox, we determined the differences between the transcriptional profiles of ER-α36 and full-length ER-α (ER-α66) in breast cancers and matched normal tissues. Methods: We analyzed ER-α36 and ER-α66 messenger RNA ( mRNA) levels in 74 pairs of breast cancers and matched normal tissues using a real-time quantitative polymerase chain reaction (PCR) assay, and correlated the results with their clinicopathological characteristics. Results: Breast cancers expressed lower ER-α36 mRNA levels than matched normal tissues regardless of their ER-α66 expression status. Down-regulation of ER-α36 mRNA was correlated with local progression, lymph node metastasis, and advanced cancer stage. The level of ER-α66 mRNA was lower in ER-α negative breast cancers compared with matched normal tissues. No differences in ER-α66 mRNA levels were observed during cancer progression. Conclusion: Down-regulation of ER-α36 is associated with carcinogenesis and progression of breast cancer. 展开更多
关键词 Breast cancer estrogen receptor estrogen receptor-α36 er-α36) er-α66
原文传递
Environmental microcystin exposure triggers the poor prognosis of prostate cancer: Evidence from case-control, animal, and in vitro studies 被引量:1
19
作者 Chun Pan Haixiang Qin +5 位作者 Minghao Yan Xuefeng Qiu Wenyue Gong Wenxin Luo Hongqian Guo Xiaodong Han 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2023年第5期69-81,共13页
Microcystin-leucine-arginine(MC-LR)is positively linked with multiple cancers in humans.However,the association between MC-LR and the risk and prognosis of prostate cancer has not been conducted in epidemiological stu... Microcystin-leucine-arginine(MC-LR)is positively linked with multiple cancers in humans.However,the association between MC-LR and the risk and prognosis of prostate cancer has not been conducted in epidemiological studies.No reported studies have linked MC-LR exposure to the poor prognosis of prostate cancer by conducting experimental studies.The content of MC-LR was detected in most of the aquatic food in wet markets and supermarkets in Nanjing and posed a health risk for consumers.MC-LR levels in both prostate cancer tissues and serum were significantly higher than controls.The adjusted odds ratio(OR)for prostate cancer risk by serum MC-LR was 1.75(95%CI:1.21-2.52)in the whole subjects,and a positive correlation between MC-LR and advanced tumor stage was observed.Survival curve analysis indicated patients with higher MC-LR levels in tissues exhibited poorer overall survival.Human,animal,and cell studies confirmed that MC-LR exposure increases the expression of estrogen receptor-α(ERα)and promotes epithelial-mesenchymal transition(EMT)in prostate cancer.Moreover,MC-LR-induced decreased E-cadherin levels,increased vimentin levels,and increased migratory and invasive capacities of prostate cancer cells were markedly suppressed upon ERαknockdown.MC-LR-induced xenograft tumor growth and lungmetastasis in BALB/c nude mice can be effectively alleviated with ERαknockdown.Our data demonstrated that MC-LR upregulated vimentin and downregulated E-cadherin through activating ERα,promoting migration and invasion of prostate cancer cells.Our findings highlight the role of MC-LR in prostate cancer,providing new perspectives to understand MC-LR-induced prostatic toxicity. 展开更多
关键词 Microcystin-leucine-arginine (MC-LR) estrogen receptor-α(ERα) Epithelial-mesenchymal transition (EMT) Prostate cancer E-cadherin Vimentin
原文传递
柴金散结方对乳腺增生大鼠的药效作用及机制 被引量:2
20
作者 李佳林 张晶璇 +3 位作者 王铁山 陈聪 任冬玲 王停 《中国实验方剂学杂志》 CAS CSCD 北大核心 2019年第15期89-95,共7页
目的:考察柴金散结方对大鼠乳腺增生的药效及机制,为中药新药研发提供实验依据。方法:外源性肌注雌、孕激素制备乳腺增生SD大鼠模型,造模成功后,大鼠按体质量随机分为正常组、模型组、柴金散结方(柴金)低、中、高剂量(3. 13,6. 26,12. 5... 目的:考察柴金散结方对大鼠乳腺增生的药效及机制,为中药新药研发提供实验依据。方法:外源性肌注雌、孕激素制备乳腺增生SD大鼠模型,造模成功后,大鼠按体质量随机分为正常组、模型组、柴金散结方(柴金)低、中、高剂量(3. 13,6. 26,12. 52 g·kg-1)组及乳癖消(0. 517 g·kg-1)组,每组9只。给药28 d,放射免疫法测定雌二醇(E2),孕酮(P)及泌乳素(PRL),计算子宫、卵巢系数,观察乳头直径、乳腺组织病理,免疫组化法测定乳腺组织中雌激素受体-α(ER-α)表达量,实时荧光定量聚合酶链式反应(Real-time PCR)测定下丘脑、垂体促性腺激素释放激素(GnRH),促性腺激素释放激素受体(GnRH-R) mRNA表达;ICR小鼠按体质量随机分为正常组、柴金低、中、高剂量组(5. 2,10. 4,20. 8 g·kg-1)与罗通定组(0. 038 6 g·kg-1),每组12只,给药7 d,末次给药30 min后腹腔注射0. 6%乙酸,观察15 min内扭体次数。结果:与正常组比较,模型组乳头直径增宽,血清E2显著升高(P <0. 01),乳腺组织增生,ER-α表达增加;与模型组比较,柴金高剂量组乳头直径显著下降(P <0. 05);柴金各剂量组E2均有下降;柴金中、高剂量组可降低乳腺增生病理积分;柴金各剂量组均能降低下丘脑中GnRH mRNA表达;柴金高剂量组小鼠扭体次数减少(P <0. 05)。结论:柴金散结方可改善乳腺增生病变情况,作用机制可能与调节下丘脑GnRH mRNA表达及降低雌激素受体表达有关。 展开更多
关键词 柴金散结方 实验性乳腺增生 药效学 雌激素受体-α(er-α) 作用机制 逍遥散
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部